by Rod Raynovich | Apr 18, 2011 | 2023-24 Life Science Portfolios, BIOgraph
Even the biotech bulls bailed today on the double whammy of concern about Europe’s debt crisis and the S&P echoing the Tea Party refrain about the U.S. budget deficit and need for fiscal reform. As of mid-day trading both the S&P 500 and the NASDAQ is...